FDA inspects specialty compounding pharmacies in targeted action
Published: March 1
By Lena H. Sun and Kimberly Kindy
In response to pressure from Congress and health-care watchdogs, federal regulators have launched an aggressive surprise inspection campaign of large specialty pharmacies, in the spotlight after a deadly meningitis outbreak last fall that was linked to tainted drugs, officials said Friday.
Inspectors from the U.S. Food and Drug Administration fanned out to 11 states and have so far found dozens of safety lapses at four facilities, including contaminated drugs, medications with no expiration dates, and drug containers that were “not clean and sterilized,” records show.